AACR: A 'tissue agnostic' indication for Retevmo? Lilly says it's possible with RET cancer win
10th April 2021 Uncategorised 0AACR: A ’tissue agnostic’ indication for Retevmo? Lilly says it’s possible with RET cancer win aliu Sat, 04/10/2021 – 10:04 More: AACR: A 'tissue agnostic' indication for Retevmo? Lilly says it's possible with RET cancer win Source: fierce
read more